![]() |
Name |
(7R,8R,8aR)-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
|
Molecular Formula | C19H26O4 | |
IUPAC Name* |
(7R,8R,8aR)-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
|
|
SMILES |
CC[C@H](C)/C=C(\C)/C=C/C1=CC2=CC(=O)[C@]([C@@H]([C@H]2CO1)O)(C)O
|
|
InChI |
InChI=1S/C19H26O4/c1-5-12(2)8-13(3)6-7-15-9-14-10-17(20)19(4,22)18(21)16(14)11-23-15/h6-10,12,16,18,21-22H,5,11H2,1-4H3/b7-6+,13-8+/t12-,16-,18+,19-/m0/s1
|
|
InChIKey |
CDNUINONZTWWCE-HESROLHBSA-N
|
|
Synonyms |
Dechloroisochromophilone III; CHEMBL5086553; (7R,8R,8aR)-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one; 3-[(1E,3E,5S)-3,5-Dimethyl-1,3-heptadienyl]-1,7,8,8aalpha-tetrahydro-7alpha,8alpha-dihydroxy-7-methyl-6H-2-benzopyran-6-one
|
|
CAS | NA | |
PubChem CID | 6475611 | |
ChEMBL ID | CHEMBL5086553 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 318.4 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.779 |
Caco-2 Permeability: | -4.652 | MDCK Permeability: | 0.00002550 |
Pgp-inhibitor: | 0.635 | Pgp-substrate: | 0.652 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.079 |
30% Bioavailability (F30%): | 0.042 |
Blood-Brain-Barrier Penetration (BBB): | 0.946 | Plasma Protein Binding (PPB): | 84.72% |
Volume Distribution (VD): | 1.895 | Fu: | 16.34% |
CYP1A2-inhibitor: | 0.519 | CYP1A2-substrate: | 0.145 |
CYP2C19-inhibitor: | 0.198 | CYP2C19-substrate: | 0.818 |
CYP2C9-inhibitor: | 0.131 | CYP2C9-substrate: | 0.622 |
CYP2D6-inhibitor: | 0.246 | CYP2D6-substrate: | 0.235 |
CYP3A4-inhibitor: | 0.456 | CYP3A4-substrate: | 0.535 |
Clearance (CL): | 5.215 | Half-life (T1/2): | 0.865 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.477 |
Drug-inuced Liver Injury (DILI): | 0.963 | AMES Toxicity: | 0.532 |
Rat Oral Acute Toxicity: | 0.742 | Maximum Recommended Daily Dose: | 0.993 |
Skin Sensitization: | 0.96 | Carcinogencity: | 0.54 |
Eye Corrosion: | 0.42 | Eye Irritation: | 0.963 |
Respiratory Toxicity: | 0.96 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005433 | ![]() |
0.814 | D0S7WX | ![]() |
0.202 | ||
ENC005434 | ![]() |
0.789 | D0E9KA | ![]() |
0.200 | ||
ENC001875 | ![]() |
0.703 | D00DKK | ![]() |
0.198 | ||
ENC004213 | ![]() |
0.595 | D0G3PI | ![]() |
0.198 | ||
ENC005431 | ![]() |
0.573 | D02DGU | ![]() |
0.198 | ||
ENC001871 | ![]() |
0.558 | D0P0HT | ![]() |
0.196 | ||
ENC001877 | ![]() |
0.558 | D0H6VY | ![]() |
0.195 | ||
ENC005432 | ![]() |
0.542 | D06WTZ | ![]() |
0.193 | ||
ENC001876 | ![]() |
0.518 | D04GJN | ![]() |
0.193 | ||
ENC005595 | ![]() |
0.489 | D0R2KF | ![]() |
0.189 |